Loading...
By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM
The current financial incentive system for U.S. hospitals has had a "limited and disappointing" effect, researchers write in The BMJ. They say that given the program's cost, policymakers have two choices: "revise the current program or potentially end it."
The researchers compared clinical process scores and 30-day mortality rates between two groups of hospitals — those that enacted financial incentives in 2003 under the Premier Hospital Quality Incentive Demonstration, and those that did so in 2011 under the current Hospital Value-Based Purchasing program. Their aim was to see if the hospitals with more pay-for-performance experience — and therefore more time to make changes needed to improve outcomes — would outperform the less experienced hospitals.
Overall, process scores and mortality rates did not differ between the more and less experienced hospitals. The researchers write, "These findings provide evidence that having additional time is not likely to turn these programs into a success, at least as far as patient outcomes are concerned."
Comment
LINK(S):
The BMJ article (Free)
Background: NEJM Journal Watch General Medicine coverage of pay-for-performance and mortality in the U.K. (Your NEJM Journal Watch registration required)